Literature DB >> 31708066

Cannabis and Health Research: Rapid Progress Requires Innovative Research Designs.

Kent E Hutchison1, L Cinnamon Bidwell2, Jarrod M Ellingson3, Angela D Bryan3.   

Abstract

The United States has witnessed enormous changes concerning the acceptance of medicinal and recreational cannabis use. Sixty-three percent of the US population has access to medicinal cannabis markets, which offer increasingly diverse and potent cannabis products. Considering the rapidly changing cultural, political, and legal landscape, the scientific literature does not adequately inform public policy, medical decision making, or harm reduction approaches. The goals of this paper are to (1) investigate the state of cannabis research on medical conditions commonly treated with cannabis, (2) review the barriers that have led to large gaps between cannabis use and available empirical data, and (3) suggest a path forward with new research designs to address these gaps. Thus, we aim to advance a more nuanced understanding of the barriers to cannabis research and suggest innovative research designs necessary for rapid development of a meaningful knowledge base.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Keywords:  CBD; FDA; THC; cannabis; external validity; marijuana; observational research

Mesh:

Substances:

Year:  2019        PMID: 31708066     DOI: 10.1016/j.jval.2019.05.005

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  9 in total

1.  The Neurocognitive Effects of Cannabis Across the Lifespan.

Authors:  Jarrod M Ellingson; Jesse D Hinckley; J Megan Ross; Joseph P Schacht; L Cinnamon Bidwell; Angela D Bryan; Christian J Hopfer; Paula Riggs; Kent E Hutchison
Journal:  Curr Behav Neurosci Rep       Date:  2021-11-15

2.  Effects of cannabidiol in cannabis flower: Implications for harm reduction.

Authors:  Laurel P Gibson; Hollis C Karoly; Jarrod M Ellingson; Jost Klawitter; Cristina Sempio; Julia E Squeri; Angela D Bryan; L Cinnamon Bidwell; Kent E Hutchison
Journal:  Addict Biol       Date:  2021-08-31       Impact factor: 4.093

3.  The phytochemical diversity of commercial Cannabis in the United States.

Authors:  Christiana J Smith; Daniela Vergara; Brian Keegan; Nick Jikomes
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

4.  Widely assumed phenotypic associations in Cannabis sativa lack a shared genetic basis.

Authors:  Daniela Vergara; Cellene Feathers; Ezra L Huscher; Ben Holmes; Jacob A Haas; Nolan C Kane
Journal:  PeerJ       Date:  2021-04-20       Impact factor: 2.984

5.  Cannabis Seeds Authentication by Chloroplast and Nuclear DNA Analysis Coupled with High-Resolution Melting Method for Quality Control Purposes.

Authors:  Leonardo Anabalón; Jaime Solano; Francisco Encina-Montoya; Marco Bustos; Alejandra Figueroa; David Gangitano
Journal:  Cannabis Cannabinoid Res       Date:  2021-06-17

6.  Development of Gas-Chromatographic Method for Simultaneous Determination of Cannabinoids and Terpenes in Hemp.

Authors:  Jure Zekič; Mitja Križman
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

7.  Cannabis Use and Resting State Functional Connectivity in the Aging Brain.

Authors:  Karli K Watson; Angela D Bryan; Rachel E Thayer; Jarrod M Ellingson; Carillon J Skrzynski; Kent E Hutchison
Journal:  Front Aging Neurosci       Date:  2022-02-10       Impact factor: 5.702

8.  Differences in Attitudes Toward Medical Cannabis With Humanized Patient Scenarios.

Authors:  Thomas A Clobes; Mya Arellano; Matin Gagnon; Colby Klaiman
Journal:  Cureus       Date:  2022-08-24

9.  Use of medical marijuana in cystic fibrosis patients.

Authors:  Michael J Stephen; Jared Chowdhury; Luis Arzeno Tejada; Robert Zanni; Denis Hadjiliadis
Journal:  BMC Complement Med Ther       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.